SavedAdd your journal

Journals / Acta Orthopaedica et Traumatologica Turcica / 2014 / Cilt: 48 - Sayı: 1

Aggressive fibromatosis: evaluation of prognostic factors and outcomes of surgical treatment

LEVENT KÜÇÜK
Burçin KEÇECİ
DÜNDAR SABAH
Güven YÜCETÜRK
Pages
55–60
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Adjuvant radiotherapy administration appears to be a rational treatment method instead of sacrificing function to achieve wide surgical margins.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the results of surgical treatment of aggressive fibromatosis and the effects of prognostic factors on recurrence.
📊
Key Findings & Data:Methods: Forty patients (24 female, 16 male; average age: 31.2 years) diagnosed with aggressive fibromatosis were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: Adjuvant radiotherapy administration appears to be a rational treatment method instead of sacrificing function to achieve wide surgical margins.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to evaluate the results of surgical treatment of aggressive fibromatosis and the effects of prognostic factors on recurrence. Methods: Forty patients (24 female, 16 male; average age: 31.2 years) diagnosed with aggressive fibromatosis were evaluated retrospectively. Nine patients with tumor-positive surgical margins macroscopically were excluded. Prognostic factors such as age, gender, localization, admission status, compartment status, surgical margin, tumor size and adjuvant radiotherapy were evaluated. Results: Recurrence rate was 29%. Average disease free survival was 46±4 months. There was no statistically significant relation between prognostic factors and recurrence. Clinical results of the patients receiving adjuvant radiotherapy were more satisfactory. Conclusion: Adjuvant radiotherapy administration appears to be a rational treatment method instead of sacrificing function to achieve wide surgical margins.

🔖

Cite This Article

KÜÇÜK, L., KEÇECİ, B., SABAH, D., YÜCETÜRK, G. (2014). Aggressive fibromatosis: evaluation of prognostic factors and outcomes of surgical treatment. Acta Orthopaedica et Traumatologica Turcica, Cilt: 48 - Sayı: 1, 55–60. https://ajindex.com/articles/353604

References (14)

  1. Dalén BP, Bergh PM, Gunterberg BU. Desmoid tumors: a clinical review of 30 patients with more than 20 years’ follow-up. Acta Orthop Scand 2003;74:455-9
  2. Yücetürk G, Sabah D, Keçeci B, Kara AD, Yalçinkaya S. Prevalence of bone and soft tissue tumors. Acta Orthop Traumatol Turc 2011;45:135-43
  3. Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS, et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 1997;39:659-65
  4. Hoffmann W, Weidmann B, Schmidberger H, Niederle N, Seeber S, Bamberg M. The clinical picture and therapy of aggressive fibromatosis (desmoids). [Article in German] Strahlenther Onkol 1993;169:235-41. [Abstract] 5. Kirschner MJ, Sauer R. The role of radiotherapy in the treatment of desmoid tumors. Strahlenther Onkol 1993;169:77-82
  5. Nakada I, Ubukata H, Goto Y, Watanabe Y, Sato S, Tabuchi T, et al. Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis. J Gastroenterol 1997;32:255-9
  6. Sørensen A, Keller J, Nielsen OS, Jensen OM. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years. Acta Orthop Scand 2002;73:213-9
  7. Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol. 2010;102:380-4
  8. Pajares B, Torres E, Jiménez B, Sevilla I, Rodríguez A, Rico JM, et al. Multimodal treatment of desmoid tumours: the significance of local control. Clin Transl Oncol 2011;13:189-93
  9. Ozger H, Eralp L, Toker B, Ağaoğlu F, Dizdar Y. Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors. Acta Orthop Traumatol Turc 2007;41:291-4
  10. Barbier O, Anract P, Pluot E, Larouserie F, Sailhan F, Babinet A, et al. Primary or recurring extra-abdominal desmoid fibromatosis: assessment of treatment by observation only. Orthop Traumatol Surg Res 2010;96:884-9
  11. Shields CJ, Winter DC, Kirwan WO, Redmond HP. Desmoid tumours. Eur J Surg Oncol 2001;27:701-6
  12. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17:158-67
  13. Goy BW, Lee SP, Fu YS, Selch MT, Eilber F. Treatment results of unresected or partially resected desmoid tumors. Am J Clin Oncol 1998;21:584-90
  14. Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk